​

MediciNova (MNOV) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

MNOV Stock Rating

MediciNova stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

MNOV Price Target Upside V Benchmarks

TypeNameUpside
StockMediciNova-
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.88$1.88$1.88
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 26-2---2
Dec, 25-2---2
Nov, 25-2---2
Oct, 25-2---2
Sep, 25-2---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change

Financial Forecast

EPS Forecast

Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$-0.21$-0.17------
Avg Forecast$-0.25$-0.21$-0.22$-0.50$-0.38$-0.40$-0.44$-0.06
High Forecast$-0.25$-0.21$-0.22$-0.50$-0.38$-0.40$-0.44$-0.06
Low Forecast$-0.25$-0.21$-0.22$-0.50$-0.38$-0.40$-0.44$-0.06
Surprise %-16.00%-19.05%------

Revenue Forecast

$40M $48M $56M $64M $72M $80M Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$4.04M$1.00M------
Avg Forecast$4.01M$1.00M$750.00K-$79.22M--$40.54M
High Forecast$4.01M$1.00M$750.00K-$79.22M--$40.54M
Low Forecast$4.01M$1.00M$750.00K-$79.22M--$40.54M
Surprise %0.62%-------

Net Income Forecast

$-25M $-20M $-15M $-10M $-5M $0 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$-10.13M$-8.57M------
Avg Forecast$-12.42M$-10.30M$-10.79M$-24.52M$-18.64M$-19.62M$-21.58M$-2.94M
High Forecast$-12.42M$-10.30M$-10.79M$-24.52M$-18.64M$-19.62M$-21.58M$-2.94M
Low Forecast$-12.42M$-10.30M$-10.79M$-24.52M$-18.64M$-19.62M$-21.58M$-2.94M
Surprise %-18.44%-16.78%------

MNOV Forecast FAQ

Is MediciNova stock a buy?

MediciNova stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that MediciNova is a favorable investment for most analysts.

What is MediciNova's price target?

MediciNova's price target, set by 4 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $1.88.

How does MediciNova stock forecast compare to its benchmarks?

MediciNova's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for MediciNova over the past three months?

  • January 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is MediciNova’s EPS forecast?

MediciNova's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.22, marking a 29.41% increase from the reported $-0.17 in 2023. Estimates for the following years are $-0.5 in 2025, $-0.38 in 2026, $-0.4 in 2027, $-0.44 in 2028, and $-0.06 in 2029.

What is MediciNova’s revenue forecast?

MediciNova's average annual revenue forecast for its fiscal year ending in December 2024 is $750K, reflecting a -25.00% decrease from the reported $1M in 2023. The forecast for 2025 is $0, followed by $79.22M for 2026, $0 for 2027, $0 for 2028, and $40.54M for 2029.

What is MediciNova’s net income forecast?

MediciNova's net income forecast for the fiscal year ending in December 2024 stands at $-10.79M, representing an 25.88% increase from the reported $-8.572M in 2023. Projections indicate $-24.523M in 2025, $-18.638M in 2026, $-19.618M in 2027, $-21.58M in 2028, and $-2.943M in 2029.